loading
전일 마감가:
$1.11
열려 있는:
$1.14
하루 거래량:
1.09M
Relative Volume:
0.65
시가총액:
$29.93M
수익:
$16.77M
순이익/손실:
$-11.87M
주가수익비율:
-2.3408
EPS:
-0.4742
순현금흐름:
$-5.90M
1주 성능:
+10.45%
1개월 성능:
+107.87%
6개월 성능:
+170.73%
1년 성능:
+12.12%
1일 변동 폭
Value
$1.05
$1.16
1주일 범위
Value
$0.82
$1.16
52주 변동 폭
Value
$0.30
$1.16

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
명칭
Immunoprecise Antibodies Ltd
Name
전화
-
Name
주소
-
Name
직원
101
Name
트위터
Name
다음 수익 날짜
2024-09-16
Name
최신 SEC 제출 서류
Name
IPA's Discussions on Twitter

IPA을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
IPA
Immunoprecise Antibodies Ltd
1.11 29.93M 16.77M -11.87M -5.90M -0.4742
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-12-02 개시 H.C. Wainwright Buy
2021-10-25 개시 The Benchmark Company Buy

Immunoprecise Antibodies Ltd 주식(IPA)의 최신 뉴스

pulisher
Jun 18, 2025

Market Recap: ImmunoPrecise Antibodies Ltd (IPA)’s Positive Momentum, Closing at 0.95 - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

We're Keeping An Eye On ImmunoPrecise Antibodies' (NASDAQ:IPA) Cash Burn Rate - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Sees Large Growth in Short Interest - Defense World

Jun 18, 2025
pulisher
Jun 13, 2025

ImmunoPrecise stock rating reiterated at Buy by H.C. Wainwright - Investing.com India

Jun 13, 2025
pulisher
Jun 12, 2025

ImmunoPrecise Antibodies (IPA) Showcases Groundbreaking AI-Desig - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Esty, America's Car-Mart, ImmunoPrecise - TradingView

Jun 12, 2025
pulisher
Jun 12, 2025

ImmunoPrecise’s AI-Designed Peptides Surpass Semaglutide in Receptor Activation - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

ImmunoPrecise Antibodies Says AI-Designed GLP-1 Peptides Surpass Semaglutide In Receptor Activation - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

AI-Designed GLP-1 Peptides from ImmunoPrecise Antibodies Surpass Semaglutide in Receptor Activation Studies - The Joplin Globe

Jun 12, 2025
pulisher
Jun 06, 2025

Immunoprecise Antibodies discovers highly conserved epitope across all four dengue virus serotypes - BioWorld MedTech

Jun 06, 2025
pulisher
Jun 06, 2025

ImmunoPrecise jumps on reported vaccine breakthrough - The Pharma Letter

Jun 06, 2025
pulisher
Jun 06, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Up 1.8% – Here’s What Happened - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

ImmunoPrecise identifies universal dengue vaccine target By Investing.com - Investing.com South Africa

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise Antibodies (IPA) Makes Breakthrough in Dengue Vacc - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Immunoprecise Announces Ai-Driven Breakthrough In Universal Dengue Vaccine Discovery - marketscreener.com

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise Unveils AI-Driven Breakthrough in Dengue Vaccine Discovery - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise identifies universal dengue vaccine target - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery | IPA Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

ImmunoPrecise Announces AI-Driven Breakthrough in Universal Dengue Vaccine Discovery - Yahoo Finance

Jun 05, 2025
pulisher
May 24, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock Rating Upgraded by Wall Street Zen - Defense World

May 24, 2025
pulisher
May 21, 2025

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Eng - GuruFocus

May 21, 2025
pulisher
May 21, 2025

ImmunoPrecise Antibodies Engages CORE IR to Enhance Investor Engagement Efforts - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group's 2025 Virtual Tech Conference | IPA Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ImmunoPrecise Antibodies to Present at Maxim Group’s 2025 Virtual Tech Conference - TipRanks

May 20, 2025
pulisher
May 20, 2025

AI Breakthrough: ImmunoPrecise CEO Reveals Next-Gen Biotherapeutics Strategy at Major Tech Conference - Stock Titan

May 20, 2025
pulisher
May 20, 2025

ImmunoPrecise Antibodies (IPA) to Present at Maxim Group’s 2025 Virtual Tech Conference - New Castle News

May 20, 2025
pulisher
May 20, 2025

What's Going on With Apple Stock? - The Globe and Mail

May 20, 2025
pulisher
May 12, 2025

ImmunoPrecise Antibodies (IPA) Showcases Breakthrough in Epitope Mapping | IPA Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

ImmunoPrecise Antibodies’ LENSai Platform Revolutionizes Epitope Mapping - TipRanks

May 12, 2025
pulisher
May 12, 2025

IPA's LENSai™ Platform Delivers X-Ray--Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed | IPA Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

IPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed - Yahoo Finance

May 12, 2025
pulisher
May 04, 2025

ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Shares Leap 28% Yet They're Still Not Telling The Full Story - simplywall.st

May 04, 2025
pulisher
Apr 28, 2025

ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 25, 2025

How ImmunoPrecise Antibodies ($IPA) Uses AI to Transform Antibody-Based Drug Discovery - Podomatic

Apr 25, 2025
pulisher
Apr 24, 2025

IPAImmunoprecise Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 24, 2025

Views of Wall Street’s Leading Experts on ImmunoPrecise Antibodies Ltd - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Down 7% – Should You Sell? - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

What is going on with ImmunoPrecise Antibodies Ltd? Sentiment Analysis - uspostnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st

Apr 22, 2025
pulisher
Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

ImmunoPrecise Antibodies’ (IPA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI- - GuruFocus

Apr 12, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - 01net

Apr 11, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing - TipRanks

Apr 11, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSaitm with FDA's Shift to Non-Animal Testing Methods - Lelezard

Apr 11, 2025
pulisher
Apr 11, 2025

AI Breakthrough: How IPA's LENSai Platform Leads FDA's Historic Shift from Animal Testing - Stock Titan

Apr 11, 2025
pulisher
Apr 10, 2025

ImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody Discovery - TipRanks

Apr 10, 2025

Immunoprecise Antibodies Ltd (IPA) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
자본화:     |  볼륨(24시간):